Year |
Citation |
Score |
2024 |
Baca CF, Yu Y, Rostøl JT, Majumder P, Patel DJ, Marraffini LA. The CRISPR effector Cam1 mediates membrane depolarization for phage defence. Nature. 625: 797-804. PMID 38200316 DOI: 10.1038/s41586-023-06902-y |
0.362 |
|
2023 |
Banh DV, Roberts CG, Morales-Amador A, Berryhill BA, Chaudhry W, Levin BR, Brady SF, Marraffini LA. Author Correction: Bacterial cGAS senses a viral RNA to initiate immunity. Nature. PMID 38052939 DOI: 10.1038/s41586-023-06929-1 |
0.747 |
|
2023 |
Banh DV, Roberts CG, Morales-Amador A, Berryhill BA, Chaudhry W, Levin BR, Brady SF, Marraffini LA. Bacterial cGAS senses a viral RNA to initiate immunity. Nature. PMID 37968393 DOI: 10.1038/s41586-023-06743-9 |
0.767 |
|
2023 |
Stella G, Marraffini L. Type III CRISPR-Cas: beyond the Cas10 effector complex. Trends in Biochemical Sciences. PMID 37949766 DOI: 10.1016/j.tibs.2023.10.006 |
0.326 |
|
2023 |
Kenney CT, Marraffini LA. Rarely acquired type II-A CRISPR-Cas spacers mediate anti-viral immunity through the targeting of a non-canonical PAM sequence. Nucleic Acids Research. PMID 37293964 DOI: 10.1093/nar/gkad501 |
0.407 |
|
2022 |
Maguin P, Varble A, Modell JW, Marraffini LA. Cleavage of viral DNA by restriction endonucleases stimulates the type II CRISPR-Cas immune response. Molecular Cell. 82: 907-919.e7. PMID 35134339 DOI: 10.1016/j.molcel.2022.01.012 |
0.374 |
|
2022 |
Aviram N, Thornal AN, Zeevi D, Marraffini LA. Different modes of spacer acquisition by the Staphylococcus epidermidis type III-A CRISPR-Cas system. Nucleic Acids Research. 50: 1661-1672. PMID 35048966 DOI: 10.1093/nar/gkab1299 |
0.772 |
|
2022 |
Barrangou R, Marraffini LA. Turning CRISPR on with antibiotics. Cell Host & Microbe. 30: 12-14. PMID 35026132 DOI: 10.1016/j.chom.2021.12.013 |
0.329 |
|
2021 |
Varble A, Campisi E, Euler CW, Maguin P, Kozlova A, Fyodorova J, Rostøl JT, Fischetti VA, Marraffini LA. Prophage integration into CRISPR loci enables evasion of antiviral immunity in Streptococcus pyogenes. Nature Microbiology. 6: 1516-1525. PMID 34819640 DOI: 10.1038/s41564-021-00996-8 |
0.428 |
|
2021 |
Hossain AA, McGinn J, Meeske AJ, Modell JW, Marraffini LA. Viral recombination systems limit CRISPR-Cas targeting through the generation of escape mutations. Cell Host & Microbe. 29: 1482-1495.e12. PMID 34582782 DOI: 10.1016/j.chom.2021.09.001 |
0.388 |
|
2021 |
Mo CY, Mathai J, Rostøl JT, Varble A, Banh DV, Marraffini LA. Type III-A CRISPR immunity promotes mutagenesis of staphylococci. Nature. 592: 611-615. PMID 33828299 DOI: 10.1038/s41586-021-03440-3 |
0.763 |
|
2021 |
Jakhanwal S, Cress BF, Maguin P, Lobba MJ, Marraffini LA, Doudna JA. A CRISPR-Cas9-integrase complex generates precise DNA fragments for genome integration. Nucleic Acids Research. PMID 33693715 DOI: 10.1093/nar/gkab123 |
0.378 |
|
2021 |
Rostøl JT, Xie W, Kuryavyi V, Maguin P, Kao K, Froom R, Patel DJ, Marraffini LA. The Card1 nuclease provides defence during type-III CRISPR immunity. Nature. PMID 33461211 DOI: 10.1038/s41586-021-03206-x |
0.367 |
|
2020 |
Nussenzweig PM, Marraffini LA. Molecular Mechanisms of CRISPR-Cas Immunity in Bacteria. Annual Review of Genetics. PMID 32857635 DOI: 10.1146/Annurev-Genet-022120-112523 |
0.461 |
|
2020 |
Meeske AJ, Jia N, Cassel AK, Kozlova A, Liao J, Wiedmann M, Patel DJ, Marraffini LA. A phage-encoded anti-CRISPR enables complete evasion of type VI-A CRISPR-Cas immunity. Science (New York, N.Y.). PMID 32467331 DOI: 10.1126/Science.Abb6151 |
0.502 |
|
2020 |
Shilton AK, Marraffini LA. Shoot the Messenger! A New Phage Weapon to Neutralize the Type III CRISPR Immune Response. Molecular Cell. 78: 568-569. PMID 32442502 DOI: 10.1016/J.Molcel.2020.04.011 |
0.401 |
|
2020 |
Pyenson NC, Marraffini LA. Co-evolution within structured bacterial communities results in multiple expansion of CRISPR loci and enhanced immunity. Elife. 9. PMID 32223887 DOI: 10.7554/Elife.53078 |
0.515 |
|
2020 |
Garcia-Doval C, Schwede F, Berk C, Rostøl JT, Niewoehner O, Tejero O, Hall J, Marraffini LA, Jinek M. Activation and self-inactivation mechanisms of the cyclic oligoadenylate-dependent CRISPR ribonuclease Csm6. Nature Communications. 11: 1596. PMID 32221291 DOI: 10.1038/S41467-020-15334-5 |
0.425 |
|
2020 |
Pyenson NC, Marraffini LA. Author response: Co-evolution within structured bacterial communities results in multiple expansion of CRISPR loci and enhanced immunity Elife. DOI: 10.7554/Elife.53078.Sa2 |
0.356 |
|
2019 |
Nussenzweig PM, McGinn J, Marraffini LA. Cas9 Cleavage of Viral Genomes Primes the Acquisition of New Immunological Memories. Cell Host & Microbe. PMID 31585845 DOI: 10.1016/J.Chom.2019.09.002 |
0.46 |
|
2019 |
Meeske AJ, Nakandakari-Higa S, Marraffini LA. Cas13-induced cellular dormancy prevents the rise of CRISPR-resistant bacteriophage. Nature. PMID 31142834 DOI: 10.1038/S41586-019-1257-5 |
0.517 |
|
2019 |
Varble A, Marraffini LA. Three New Cs for CRISPR: Collateral, Communicate, Cooperate. Trends in Genetics : Tig. PMID 31036344 DOI: 10.1016/J.Tig.2019.03.009 |
0.476 |
|
2019 |
Varble A, Meaden S, Barrangou R, Westra ER, Marraffini LA. Recombination between phages and CRISPR-cas loci facilitates horizontal gene transfer in staphylococci. Nature Microbiology. PMID 30886355 DOI: 10.1038/S41564-019-0400-2 |
0.46 |
|
2019 |
Rostøl JT, Marraffini L. (Ph)ighting Phages: How Bacteria Resist Their Parasites. Cell Host & Microbe. 25: 184-194. PMID 30763533 DOI: 10.1016/J.Chom.2019.01.009 |
0.388 |
|
2019 |
Heler R, Wright AV, Vucelja M, Doudna JA, Marraffini LA. Spacer Acquisition Rates Determine the Immunological Diversity of the Type II CRISPR-Cas Immune Response. Cell Host & Microbe. PMID 30709780 DOI: 10.1016/J.Chom.2018.12.016 |
0.457 |
|
2019 |
Rostøl JT, Marraffini LA. Non-specific degradation of transcripts promotes plasmid clearance during type III-A CRISPR-Cas immunity. Nature Microbiology. PMID 30692669 DOI: 10.1038/S41564-018-0353-X |
0.513 |
|
2019 |
Wang L, Mo CY, Wasserman MR, Rostøl JT, Marraffini LA, Liu S. Dynamics of Cas10 Govern Discrimination between Self and Non-self in Type III CRISPR-Cas Immunity. Molecular Cell. 73: 278-290.e4. PMID 30503774 DOI: 10.1016/J.Molcel.2018.11.008 |
0.446 |
|
2018 |
Jia N, Mo CY, Wang C, Eng ET, Marraffini LA, Patel DJ. Type III-A CRISPR-Cas Csm Complexes: Assembly, Periodic RNA Cleavage, DNase Activity Regulation, and Autoimmunity. Molecular Cell. PMID 30503773 DOI: 10.1016/J.Molcel.2018.11.007 |
0.454 |
|
2018 |
Mo CY, Marraffini LA. If You'd Like to Stop a Type III CRISPR Ribonuclease, Then You Should Put a Ring (Nuclease) on It. Molecular Cell. 72: 608-609. PMID 30444997 DOI: 10.1016/J.Molcel.2018.10.048 |
0.41 |
|
2018 |
McGinn J, Marraffini LA. Molecular mechanisms of CRISPR-Cas spacer acquisition. Nature Reviews. Microbiology. PMID 30171202 DOI: 10.1038/S41579-018-0071-7 |
0.461 |
|
2018 |
Meeske AJ, Marraffini LA. RNA Guide Complementarity Prevents Self-Targeting in Type VI CRISPR Systems. Molecular Cell. PMID 30122537 DOI: 10.1016/J.Molcel.2018.07.013 |
0.476 |
|
2018 |
Nussenzweig PM, Marraffini LA. Viral Teamwork Pushes CRISPR to the Breaking Point. Cell. 174: 772-774. PMID 30096306 DOI: 10.1016/J.Cell.2018.07.025 |
0.315 |
|
2018 |
Clarke R, Heler R, MacDougall MS, Yeo NC, Chavez A, Regan M, Hanakahi L, Church GM, Marraffini LA, Merrill BJ. Enhanced Bacterial Immunity and Mammalian Genome Editing via RNA-Polymerase-Mediated Dislodging of Cas9 from Double-Strand DNA Breaks. Molecular Cell. 71: 42-55.e8. PMID 29979968 DOI: 10.1016/J.Molcel.2018.06.005 |
0.493 |
|
2018 |
Goldberg GW, McMillan EA, Varble A, Modell JW, Samai P, Jiang W, Marraffini LA. Incomplete prophage tolerance by type III-A CRISPR-Cas systems reduces the fitness of lysogenic hosts. Nature Communications. 9: 61. PMID 29302058 DOI: 10.1038/S41467-017-02557-2 |
0.443 |
|
2017 |
Pyenson NC, Marraffini LA. Type III CRISPR-Cas systems: when DNA cleavage just isn't enough. Current Opinion in Microbiology. 37: 150-154. PMID 28865392 DOI: 10.1016/J.Mib.2017.08.003 |
0.435 |
|
2017 |
Pyenson NC, Gayvert K, Varble A, Elemento O, Marraffini LA. Broad Targeting Specificity during Bacterial Type III CRISPR-Cas Immunity Constrains Viral Escape. Cell Host & Microbe. PMID 28826839 DOI: 10.1016/J.Chom.2017.07.016 |
0.44 |
|
2017 |
Niewoehner O, Garcia-Doval C, Rostøl JT, Berk C, Schwede F, Bigler L, Hall J, Marraffini LA, Jinek M. Type III CRISPR-Cas systems produce cyclic oligoadenylate second messengers. Nature. PMID 28722012 DOI: 10.1038/Nature23467 |
0.467 |
|
2017 |
Modell JW, Jiang W, Marraffini LA. CRISPR-Cas systems exploit viral DNA injection to establish and maintain adaptive immunity. Nature. PMID 28355179 DOI: 10.1038/Nature21719 |
0.466 |
|
2017 |
Marraffini LA. Sensing danger. Proceedings of the National Academy of Sciences of the United States of America. 114: 15-16. PMID 27999179 DOI: 10.1073/Pnas.1618747114 |
0.482 |
|
2016 |
Heler R, Wright AV, Vucelja M, Bikard D, Doudna JA, Marraffini LA. Mutations in Cas9 Enhance the Rate of Acquisition of Viral Spacer Sequences during the CRISPR-Cas Immune Response. Molecular Cell. PMID 28017588 DOI: 10.1016/J.Molcel.2016.11.031 |
0.504 |
|
2016 |
McGinn J, Marraffini LA. CRISPR-Cas Systems Optimize Their Immune Response by Specifying the Site of Spacer Integration. Molecular Cell. 64: 616-623. PMID 27618488 DOI: 10.1016/J.Molcel.2016.08.038 |
0.395 |
|
2016 |
Sontheimer EJ, Marraffini LA. RNA. CRISPR goes retro. Science (New York, N.Y.). 351: 920-1. PMID 26917756 DOI: 10.1126/Science.Aaf2851 |
0.688 |
|
2016 |
Jiang W, Samai P, Marraffini LA. Degradation of Phage Transcripts by CRISPR-Associated RNases Enables Type III CRISPR-Cas Immunity. Cell. PMID 26853474 DOI: 10.1016/J.Cell.2015.12.053 |
0.48 |
|
2016 |
Maniv I, Jiang W, Bikard D, Marraffini LA. Impact of different target sequences on type III CRISPR-Cas immunity. Journal of Bacteriology. PMID 26755632 DOI: 10.1128/Jb.00897-15 |
0.457 |
|
2015 |
Goldberg GW, Marraffini LA. Resistance and tolerance to foreign elements by prokaryotic immune systems - curating the genome. Nature Reviews. Immunology. 15: 717-24. PMID 26494050 DOI: 10.1038/Nri3910 |
0.401 |
|
2015 |
Marraffini LA. CRISPR-Cas immunity in prokaryotes. Nature. 526: 55-61. PMID 26432244 DOI: 10.1038/Nature15386 |
0.491 |
|
2015 |
Jiang W, Marraffini LA. CRISPR-Cas: New Tools for Genetic Manipulations from Bacterial Immunity Systems. Annual Review of Microbiology. 69: 209-28. PMID 26209264 DOI: 10.1146/Annurev-Micro-091014-104441 |
0.508 |
|
2015 |
Samai P, Pyenson N, Jiang W, Goldberg GW, Hatoum-Aslan A, Marraffini LA. Co-transcriptional DNA and RNA Cleavage during Type III CRISPR-Cas Immunity. Cell. 161: 1164-74. PMID 25959775 DOI: 10.1016/J.Cell.2015.04.027 |
0.513 |
|
2015 |
Heler R, Samai P, Modell JW, Weiner C, Goldberg GW, Bikard D, Marraffini LA. Cas9 specifies functional viral targets during CRISPR-Cas adaptation. Nature. 519: 199-202. PMID 25707807 DOI: 10.1038/Nature14245 |
0.461 |
|
2014 |
Bikard D, Euler CW, Jiang W, Nussenzweig PM, Goldberg GW, Duportet X, Fischetti VA, Marraffini LA. Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials. Nature Biotechnology. 32: 1146-50. PMID 25282355 DOI: 10.1038/Nbt.3043 |
0.425 |
|
2014 |
Goldberg GW, Jiang W, Bikard D, Marraffini LA. Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targeting. Nature. 514: 633-7. PMID 25174707 DOI: 10.1038/Nature13637 |
0.477 |
|
2014 |
Charpentier E, Marraffini LA. Harnessing CRISPR-Cas9 immunity for genetic engineering. Current Opinion in Microbiology. 19: 114-9. PMID 25048165 DOI: 10.1016/J.Mib.2014.07.001 |
0.501 |
|
2014 |
Heler R, Marraffini LA, Bikard D. Adapting to new threats: the generation of memory by CRISPR-Cas immune systems. Molecular Microbiology. 93: 1-9. PMID 24806524 DOI: 10.1111/Mmi.12640 |
0.478 |
|
2014 |
Barrangou R, Marraffini LA. CRISPR-Cas systems: Prokaryotes upgrade to adaptive immunity. Molecular Cell. 54: 234-44. PMID 24766887 DOI: 10.1016/J.Molcel.2014.03.011 |
0.485 |
|
2014 |
Hatoum-Aslan A, Marraffini LA. Impact of CRISPR immunity on the emergence and virulence of bacterial pathogens. Current Opinion in Microbiology. 17: 82-90. PMID 24581697 DOI: 10.1016/J.Mib.2013.12.001 |
0.443 |
|
2014 |
Hatoum-Aslan A, Maniv I, Samai P, Marraffini LA. Genetic characterization of antiplasmid immunity through a type III-A CRISPR-Cas system. Journal of Bacteriology. 196: 310-7. PMID 24187086 DOI: 10.1128/Jb.01130-13 |
0.457 |
|
2013 |
Marraffini LA. CRISPR-Cas immunity against phages: its effects on the evolution and survival of bacterial pathogens. Plos Pathogens. 9: e1003765. PMID 24348245 DOI: 10.1371/Journal.Ppat.1003765 |
0.501 |
|
2013 |
Bikard D, Marraffini LA. Control of gene expression by CRISPR-Cas systems. F1000prime Reports. 5: 47. PMID 24273648 DOI: 10.12703/P5-47 |
0.389 |
|
2013 |
Jiang W, Maniv I, Arain F, Wang Y, Levin BR, Marraffini LA. Dealing with the evolutionary downside of CRISPR immunity: bacteria and beneficial plasmids. Plos Genetics. 9: e1003844. PMID 24086164 DOI: 10.1371/Journal.Pgen.1003844 |
0.448 |
|
2013 |
Hatoum-Aslan A, Samai P, Maniv I, Jiang W, Marraffini LA. A ruler protein in a complex for antiviral defense determines the length of small interfering CRISPR RNAs. The Journal of Biological Chemistry. 288: 27888-97. PMID 23935102 DOI: 10.1074/Jbc.M113.499244 |
0.452 |
|
2013 |
Hsu PD, Scott DA, Weinstein JA, Ran FA, Konermann S, Agarwala V, Li Y, Fine EJ, Wu X, Shalem O, Cradick TJ, Marraffini LA, Bao G, Zhang F. DNA targeting specificity of RNA-guided Cas9 nucleases. Nature Biotechnology. 31: 827-32. PMID 23873081 DOI: 10.1038/Nbt.2647 |
0.386 |
|
2013 |
Bikard D, Jiang W, Samai P, Hochschild A, Zhang F, Marraffini LA. Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system. Nucleic Acids Research. 41: 7429-37. PMID 23761437 DOI: 10.1093/Nar/Gkt520 |
0.417 |
|
2013 |
Maniv I, Hatoum-Aslan A, Marraffini LA. CRISPR decoys: competitive inhibitors of CRISPR immunity. Rna Biology. 10: 694-9. PMID 23584158 DOI: 10.4161/Rna.24287 |
0.469 |
|
2013 |
Jiang W, Bikard D, Cox D, Zhang F, Marraffini LA. RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nature Biotechnology. 31: 233-9. PMID 23360965 DOI: 10.1038/Nbt.2508 |
0.441 |
|
2013 |
Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA, Zhang F. Multiplex genome engineering using CRISPR/Cas systems. Science (New York, N.Y.). 339: 819-23. PMID 23287718 DOI: 10.1126/Science.1231143 |
0.464 |
|
2012 |
Bikard D, Hatoum-Aslan A, Mucida D, Marraffini LA. CRISPR interference can prevent natural transformation and virulence acquisition during in vivo bacterial infection. Cell Host & Microbe. 12: 177-86. PMID 22901538 DOI: 10.1016/J.Chom.2012.06.003 |
0.405 |
|
2012 |
Bikard D, Marraffini LA. Innate and adaptive immunity in bacteria: mechanisms of programmed genetic variation to fight bacteriophages. Current Opinion in Immunology. 24: 15-20. PMID 22079134 DOI: 10.1016/J.Coi.2011.10.005 |
0.432 |
|
2011 |
Hatoum-Aslan A, Maniv I, Marraffini LA. Mature clustered, regularly interspaced, short palindromic repeats RNA (crRNA) length is measured by a ruler mechanism anchored at the precursor processing site. Proceedings of the National Academy of Sciences of the United States of America. 108: 21218-22. PMID 22160698 DOI: 10.1073/Pnas.1112832108 |
0.414 |
|
2010 |
Sontheimer EJ, Marraffini LA. Microbiology: slicer for DNA. Nature. 468: 45-6. PMID 21048757 DOI: 10.1038/468045A |
0.657 |
|
2010 |
Marraffini LA. Impact of CRIPSR immunity on the emergence of bacterial pathogens. Future Microbiology. 5: 693-5. PMID 20441541 DOI: 10.2217/Fmb.10.38 |
0.398 |
|
2010 |
Marraffini LA, Sontheimer EJ. CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea. Nature Reviews. Genetics. 11: 181-90. PMID 20125085 DOI: 10.1038/Nrg2749 |
0.694 |
|
2010 |
Marraffini LA, Sontheimer EJ. Self versus non-self discrimination during CRISPR RNA-directed immunity. Nature. 463: 568-71. PMID 20072129 DOI: 10.1038/Nature08703 |
0.68 |
|
2009 |
Marraffini LA, Sontheimer EJ. Invasive DNA, chopped and in the CRISPR. Structure (London, England : 1993). 17: 786-8. PMID 19523896 DOI: 10.1016/J.Str.2009.05.002 |
0.617 |
|
2008 |
Marraffini LA, Sontheimer EJ. CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA. Science (New York, N.Y.). 322: 1843-5. PMID 19095942 DOI: 10.1126/Science.1165771 |
0.659 |
|
2008 |
Budzik JM, Marraffini LA, Souda P, Whitelegge JP, Faull KF, Schneewind O. Amide bonds assemble pili on the surface of bacilli Proceedings of the National Academy of Sciences of the United States of America. 105: 10215-10220. PMID 18621716 DOI: 10.1073/Pnas.0803565105 |
0.748 |
|
2007 |
Budzik JM, Marraffini LA, Schneewind O. Assembly of pili on the surface of Bacillus cereus vegetative cells Molecular Microbiology. 66: 495-510. PMID 17897374 DOI: 10.1111/J.1365-2958.2007.05939.X |
0.766 |
|
2007 |
Marraffini LA, Schneewind O. Sortase C-mediated anchoring of BasI to the cell wall envelope of Bacillus anthracis Journal of Bacteriology. 189: 6425-6436. PMID 17586639 DOI: 10.1128/Jb.00702-07 |
0.575 |
|
2006 |
Marraffini LA, Schneewind O. Targeting proteins to the cell wall of sporulating Bacillus anthracis Molecular Microbiology. 62: 1402-1417. PMID 17074072 DOI: 10.1111/J.1365-2958.2006.05469.X |
0.563 |
|
2006 |
Marraffini LA, Dedent AC, Schneewind O. Sortases and the art of anchoring proteins to the envelopes of gram-positive bacteria Microbiology and Molecular Biology Reviews. 70: 192-221. PMID 16524923 DOI: 10.1128/Mmbr.70.1.192-221.2006 |
0.778 |
|
2005 |
Gaspar AH, Marraffini LA, Glass EM, Debord KL, Ton-That H, Schneewind O. Bacillus anthracis sortase A (SrtA) anchors LPXTG motif-containing surface proteins to the cell wall envelope. Journal of Bacteriology. 187: 4646-55. PMID 15968076 DOI: 10.1128/Jb.187.13.4646-4655.2005 |
0.715 |
|
2005 |
Marraffini LA, Schneewind O. Anchor structure of staphylococcal surface proteins: V. Anchor structure of the sortase B substrate IsdC Journal of Biological Chemistry. 280: 16263-16271. PMID 15718231 DOI: 10.1074/Jbc.M500071200 |
0.576 |
|
2004 |
Ton-That H, Marraffini LA, Schneewind O. Protein sorting to the cell wall envelope of Gram-positive bacteria. Biochimica Et Biophysica Acta. 1694: 269-78. PMID 15546671 DOI: 10.1016/J.Bbamcr.2004.04.014 |
0.721 |
|
2004 |
Marraffini LA, Ton-That H, Zong Y, Narayana SV, Schneewind O. Anchoring of surface proteins to the cell wall of Staphylococcus aureus. A conserved arginine residue is required for efficient catalysis of sortase A. The Journal of Biological Chemistry. 279: 37763-70. PMID 15247224 DOI: 10.1074/Jbc.M405282200 |
0.673 |
|
2004 |
Ton-That H, Marraffini LA, Schneewind O. Sortases and pilin elements involved in pilus assembly of Corynebacterium diphtheriae. Molecular Microbiology. 53: 251-61. PMID 15225319 DOI: 10.1111/J.1365-2958.2004.04117.X |
0.706 |
|
Show low-probability matches. |